C. This is related to its size and binding to the cellular receptor FcRn, which rescues albumin from intracellular degradation. Furthermore, the long half-life has fostered a great and increasing desire for utilization of albumin as a carrier of protein therapeutics and chemical drugs. However, to fully understand how FcRn functions as a regulator of albumin homeostasis and to take advantage of the FcRn-albumin conversation in drug design, the conversation interface needs to be dissected. Here, we used a panel of monoclonal antibodies directed towards human FcRn in combination with site-directed mutagenesis and structural modeling to unmask the binding sites for URMC-099 albumin blocking antibodies and albumin around the receptor, which revealed that this conversation is not only purely pH-dependent, but predominantly hydrophobic in URMC-099 nature. Specifically, we provide mechanistic evidence for a crucial role of a cluster of conserved tryptophan residues that expose a pH-sensitive loop of FcRn, and identify structural differences in proximity to these hot spot residues that explain divergent cross-species binding properties of FcRn. Our findings expand our knowledge of how FcRn is usually controlling albumin homeostasis URMC-099 at a molecular level, which will guideline design and engineering of novel albumin variants with altered transport properties. Keywords: Albumin, Antibody, Biodegradation, Bioengineering, Fc Receptor, pH Regulation, FcRn, Half-life, Hydrophobic Introduction Albumin is usually a product of hepatocytes and is the most abundant protein in blood (34C54 g/liter). It serves as versatile transporter of a wide range of endogenous and exogenous compounds such as metal ions, hormones, fatty acids, metabolites, toxins, and drugs (1). Similar to all serum proteins, its serum concentration is determined by its rate of synthesis and its size above the renal clearance threshold. However, a third feature of albumin that is only shared with IgG antibodies (Abs)5 is usually a greatly extended persistence in the circulatory system, which in both cases is usually caused by their Rabbit Polyclonal to NPHP4 conversation with the neonatal Fc receptor (FcRn) (1,C5). As implied by its name, FcRn was first recognized as the neonatal transporter of maternal IgG from mother’s milk across the intestinal barrier to the blood of rats (6). It also proved to be the transporter of IgG across the maternofetal barrier in both humans and rodents (7,C9). A large body of subsequent evidence has revealed that FcRn is usually expressed and functionally operative in a broad range of cells and tissues throughout life (10, 11), transporting IgG across epithelial and endothelial barriers, enhancing IgG-mediated antigen presentation by dendritic cells and phagocytosis by neutrophils (12,C16), and substantially extending the serum persistence of IgG (17,C20). As FcRn has also been demonstrated to prolong the serum half-life of albumin (5, 20), it functions as a regulator of the circulatory half-life of two totally unrelated proteins. This is obvious from the fact that mice lacking FcRn have serum levels of IgG and albumin 4C5 and 2C3-fold lower than normal mice, respectively, as do mice where FcRn is usually conditionally deleted in endothelial and hematopoietic cells (5, 20,C22). URMC-099 Genetic linkage in humans is also found by the rare human disease, familial hypercatabolic hypoproteinemia, which is usually characterized by abnormally low levels of both ligands that correlates with FcRn expression deficiency (23). FcRn is usually a major histocompatibility class I-related molecule consisting of a unique transmembrane heavy chain (HC) with three extracellular domains (1, 2, and 3) that are non-covalently bound to the common soluble 2-microglobulin. Crystal structures of the extracellular a part of FcRn show that this amino-terminal 1-2 platform is made up of eight antiparallel -pleated strands topped by two long -helices followed by the 3-domain name (24,C26). The soluble 2-microglobulin is usually tightly bound.